Comparative efficacy of behavioral despair models in depicting antidepressant-like effect of tramadol

Amitabh A. Kumar, Jayashree D, Sujith Tumkur Rajashekar

Abstract


Background: Experimental evaluation of antidepressants (ADs) in diverse animal models is the need of time. There is a constant search for newer models with ease and rapid screening of AD activity. As earlier studies highlight AD effect of tramadol in animal models, the study was undertaken to compare antidepressant-like effect of tramadol in two models of behavioural despair in mice.

Methods: Tramadol was administered intraperitoneally (i.p.) at two different doses of 20 and 40 mg/kg, once daily for 7 days to Swiss albino mice. The immobility period of control and drug-treated mice was recorded in tail suspension test (TST) and forced swim test (FST). The antidepressant (AD) effect of tramadol was compared with control (NS) and reference drug imipramine (10 mg/kg, p.o.), administered orally (p.o.) for seven successive days.

Results: Tramadol in tail suspension test (TST) produced significant antidepressant effect at 20 and 40 mg/kg doses, as depicted by reduction in immobility period of drug-treated mice compared to control group. The efficacy of tramadol at dose of 40 mg/kg was comparable to that of imipramine treated group (p<0.001).

Tramadol in forced swim test (FST) produced significant antidepressant effect only at the dose of 40 mg/kg as compared to control, while the results were insignificant as compared to imipramine treated group (p>0.05).

Conclusion: The results of the present study depict antidepressant-like activity of tramadol in both the models of depression TST and FST. But TST in mice seems to be more efficacious in appraising the antidepressant like effect of tramadol.


Keywords


Antidepressant, Forced swim test (FST), Noradrenaline, Serotonin, Tail suspension test (TST), Tramadol

Full Text:

PDF

References


Matthews K, Christmas D, Swan J, Sorell E. Animal models of depression: Navigating through the clinical fog. Neurosci. Biobehav. Rev. 2005; 29: 503-513.

Baghai TC, Volz HP, Moller HJ. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities. World J. Biol. Psychiatry. 2006; 7:198-222.

Slattery DA, Hudson AL, Nutt DJ. Invited review: The evolution of antidepressant mechanisms. Fundam. Clin. Pharmacol. 2004; 18:1-21.

Bosker FJ, Westerink BH, Cremers TI, Gerrits M, van der Hart MG, Kuipers SD, van der Horst PG, den Boer JA, Korf J. Future antidepressants: what is in the pipeline and what is missing? CNS Drugs. 2004; 18:705-732.

Berton O, Nestler EJ. New approaches to antidepressant drug discovery: Beyond the monoanines. Nat. Rev. Neurosci. 2006; 7:137-151.

Porsolt RD, Le Pichon M, Jalfre M. Depression: A new animal model sensitive to antidepressant treatment. Nature. 1977; 266:730-732.

Castagn´e V, Porsolt RD, Moser P. Early behavioral screening for antidepressants and anxiolytics. Drug Dev. Res. 2006; 67:729-742.

St´eru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology. 1985; 85:367-370.

Rojas-Corrales MO, Gibert-Rahola J, Mico JA. Tramadol induces antidepressant-type effects in mice. Life Sci. 1998; 63:PL175-80.

Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther. 1993; 267(1):331-40.

Desmeules JA, Piquet V, Collart L, Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol. 1996; 41:7-12.

Sevcik J, Nieber K, Driessen B, Illes P. Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones. Br J Pharmacol. 1993;110:169-76.

Kiayias JA, Vlacchou ED, Lakka Papadodima E. Venlafaxime HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care. 2000;23:699.

Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci. 2002;72:143-52.

Spencer C. The efficacy of intramuscular tramadol as a rapid-onset antidepressant. Aust N Z J Psychiatry. 2000; 34:1032-3.

Shapira NA, Verduin ML, Degraw JD. Treatment of refractory major depression with tramadol hydrochloride monotherapy. J Clin Psychol. 2001; 62:205-6.

Sunoh Kwon, Bombi Lee, Myunghwan Kim, Hyejung Lee, Hi-Joon Park, Dae-Hyun Hahm. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Neuro-Psychopharmacol & Biol Psychiat 2010;34:265-270.

Nadège Ripoll, Denis Joseph Paul David, Eric Dailly, Martine Hascoet, Michel Bourin. Antidepressant-like effects in various mice strains in the tail suspension test. Behavioural Brain Res 2003;143:193-200.

Curran-Everette D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society. Am J Physiol Regular Integr Comp Physiol 2004; 287:247-249.

Mahmoudi M, Ebrahimzadeh MA, Ansaroudi F, Nabavi SF, Nabavi SM. Antidepressant and antioxidant activities of Artemisia absinthium L. at flowering stage. Afr J Biotechnol. 2009;8:7170–5

Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984;83:1-16.

Stahl SM. Psychopharmacology of antidepressants. London: Martin Dunitz Publisher; ISBN 1-85317-513-7.

Tayal V, Singh BK and Chawla S. Evaluation of antidepressant activity of tramadol in mice. Ind J Pharmacol 2008; 40(3):129-130.

Castagn´e V, Moser, P, Roux S, Porsolt RD. Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice. Current Protocols in Pharmacology. 2010; 49:5.8.1-5.8.14.